GB0229820D0 - Novel compounds - Google Patents

Novel compounds

Info

Publication number
GB0229820D0
GB0229820D0 GB0229820A GB0229820A GB0229820D0 GB 0229820 D0 GB0229820 D0 GB 0229820D0 GB 0229820 A GB0229820 A GB 0229820A GB 0229820 A GB0229820 A GB 0229820A GB 0229820 D0 GB0229820 D0 GB 0229820D0
Authority
GB
United Kingdom
Prior art keywords
novel compounds
novel
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB0229820A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Priority to GB0229820A priority Critical patent/GB0229820D0/en
Publication of GB0229820D0 publication Critical patent/GB0229820D0/en
Priority to MYPI20034867A priority patent/MY138478A/en
Priority to PL397229A priority patent/PL397229A1/en
Priority to AU2003294909A priority patent/AU2003294909B2/en
Priority to PL377315A priority patent/PL220722B1/en
Priority to BR0317483-2A priority patent/BR0317483A/en
Priority to CA2509413A priority patent/CA2509413C/en
Priority to MXPA05006567A priority patent/MXPA05006567A/en
Priority to ES09168438T priority patent/ES2401216T3/en
Priority to KR1020077019049A priority patent/KR100897642B1/en
Priority to ES09168436T priority patent/ES2401319T3/en
Priority to JP2005502553A priority patent/JP4584831B2/en
Priority to DE60329123T priority patent/DE60329123D1/en
Priority to KR1020057011441A priority patent/KR100765027B1/en
Priority to PCT/EP2003/014556 priority patent/WO2004056369A1/en
Priority to PT03785885T priority patent/PT1572215E/en
Priority to US10/539,385 priority patent/US7696193B2/en
Priority to EP09168438A priority patent/EP2133340B1/en
Priority to NZ540148A priority patent/NZ540148A/en
Priority to AT03785885T priority patent/ATE441417T1/en
Priority to ES03785885T priority patent/ES2333008T3/en
Priority to TW092135892A priority patent/TWI323256B/en
Priority to EP09168436A priority patent/EP2186516B1/en
Priority to RU2005122932/04A priority patent/RU2388752C2/en
Priority to SI200331706T priority patent/SI1572215T1/en
Priority to ARP030104722A priority patent/AR042542A1/en
Priority to EP03785885A priority patent/EP1572215B1/en
Priority to RU2009138602/04A priority patent/RU2423353C1/en
Priority to DK03785885T priority patent/DK1572215T3/en
Priority to CNB2003801063648A priority patent/CN1326838C/en
Priority to ZA200504270A priority patent/ZA200504270B/en
Priority to IL169091A priority patent/IL169091A/en
Priority to EGNA2005000295 priority patent/EG25204A/en
Priority to NO20053384A priority patent/NO331068B1/en
Priority to IS7941A priority patent/IS2907B/en
Priority to MA28405A priority patent/MA27582A1/en
Priority to HK06103210.2A priority patent/HK1085647A1/en
Priority to US11/831,191 priority patent/US7704994B2/en
Priority to US12/339,145 priority patent/US7799773B2/en
Priority to CY20091101260T priority patent/CY1109558T1/en
Priority to IL202827A priority patent/IL202827A/en
Priority to US12/707,147 priority patent/US8207331B2/en
Priority to JP2010157004A priority patent/JP5315299B2/en
Priority to NO20110408A priority patent/NO332218B1/en
Ceased legal-status Critical Current

Links

GB0229820A 2002-12-20 2002-12-20 Novel compounds Ceased GB0229820D0 (en)

Priority Applications (44)

Application Number Priority Date Filing Date Title
GB0229820A GB0229820D0 (en) 2002-12-20 2002-12-20 Novel compounds
CNB2003801063648A CN1326838C (en) 2002-12-20 2003-12-18 Benzo[d]azepine derivatives for the treatment of neurological disorders
ES03785885T ES2333008T3 (en) 2002-12-20 2003-12-18 DERIVATIVES OF BENZO (D) AZEPIN FOR THE TREATMENT OF NEUROLOGICAL DISORDERS.
EP09168436A EP2186516B1 (en) 2002-12-20 2003-12-18 Novel benzazepine derivative
AU2003294909A AU2003294909B2 (en) 2002-12-20 2003-12-18 Benzazepine derivatives for the treatment of neurological disorders
PL397229A PL397229A1 (en) 2002-12-20 2003-12-18 Benzodiazepine derivatives for treating neurological diseases
BR0317483-2A BR0317483A (en) 2002-12-20 2003-12-18 Benzodiazepine derivatives for the treatment of neurological disorders
CA2509413A CA2509413C (en) 2002-12-20 2003-12-18 Benzazepine derivatives for the treatment of neurological disorders
MXPA05006567A MXPA05006567A (en) 2002-12-20 2003-12-18 BENZO aC¦ D!AZEPINE DERIVATIVES FOR THE TREATMENT OF NEUROLOGICAL DISORDERS.
ES09168438T ES2401216T3 (en) 2002-12-20 2003-12-18 New benzazepine derivatives
KR1020077019049A KR100897642B1 (en) 2002-12-20 2003-12-18 Benzazepine Derivatives for the Treatment of Neurological Disorders
ES09168436T ES2401319T3 (en) 2002-12-20 2003-12-18 New benzazepine derivative
TW092135892A TWI323256B (en) 2002-12-20 2003-12-18 Novel benzazepine derivatives and pharmaceutical compositions comprising said compounds
DE60329123T DE60329123D1 (en) 2002-12-20 2003-12-18 BENZOEDETAZEPINE DERIVATIVES FOR THE TREATMENT OF NEUROLOGICAL DISEASES
RU2005122932/04A RU2388752C2 (en) 2002-12-20 2003-12-18 (3-CYCLOALKYL-2, 3, 4, 5 - TETRAHYDRO-1H-BENZO [d] AZEPIN-7-YLOXY) DERIVATIVES, USE THEREOF FOR INHIBITING H3 RECEPTORS, PHARMACEUTICAL COMPOSITION AND PREPARATION METHOD
PCT/EP2003/014556 WO2004056369A1 (en) 2002-12-20 2003-12-18 Benzo ‘ d!azepine derivatives for the treatment of neurological disorders
PT03785885T PT1572215E (en) 2002-12-20 2003-12-18 Benzo[d]azepine derivatives for the treatment of neurological disorders
US10/539,385 US7696193B2 (en) 2002-12-20 2003-12-18 Benzazepine derivatives for the treatment of neurological disorders
EP09168438A EP2133340B1 (en) 2002-12-20 2003-12-18 Novel benzazepine derivatives
NZ540148A NZ540148A (en) 2002-12-20 2003-12-18 Benzazepine derivatives for the treatment of neurological disorders
AT03785885T ATE441417T1 (en) 2002-12-20 2003-12-18 BENZOADUAZEPINE DERIVATIVES FOR THE TREATMENT OF NEUROLOGICAL DISEASES
MYPI20034867A MY138478A (en) 2002-12-20 2003-12-18 Benzazepine derivatives for the treatment of neurological disorders
JP2005502553A JP4584831B2 (en) 2002-12-20 2003-12-18 Benzazepine derivatives for the treatment of diseases of the nervous system
PL377315A PL220722B1 (en) 2002-12-20 2003-12-18 Benzo[d]azepine derivatives for the treatment of neurological disorders
KR1020057011441A KR100765027B1 (en) 2002-12-20 2003-12-18 Benzazepine Derivatives for the Treatment of Neurological Disorders
SI200331706T SI1572215T1 (en) 2002-12-20 2003-12-18 BENZO?áD?åAZEPINE DERIVATIVES FOR THE TREATMENT OF NEUROLOGICAL DISORDERS
ARP030104722A AR042542A1 (en) 2002-12-20 2003-12-18 BENZAZEPINE COMPOUND, PHARMACEUTICAL COMPOSITION THAT INCLUDES IT, USE OF THE SAME FOR THE MANUFACTURE OF A MEDICINAL PRODUCT AND PROCESS FOR PREPARATION
EP03785885A EP1572215B1 (en) 2002-12-20 2003-12-18 Benzo[d]azepine derivatives for the treatment of neurological disorders
RU2009138602/04A RU2423353C1 (en) 2002-12-20 2003-12-18 New benzazepin derivatives
DK03785885T DK1572215T3 (en) 2002-12-20 2003-12-18 Benzo [D] azepine derivatives for the treatment of neurological disorders
ZA200504270A ZA200504270B (en) 2002-12-20 2005-05-25 Benzo diazepine derivatives for the treatment of neurological disorders
IL169091A IL169091A (en) 2002-12-20 2005-06-09 Benzo[d]azepine derivatives, pharmaceutical compositions comprising them and use thereof in the manufacture of medicaments for use in the treatment of neurological disease or a psychiatric disorder
EGNA2005000295 EG25204A (en) 2002-12-20 2005-06-14 Benzo diazepine derivatives for the treatment of neurological disorders
NO20053384A NO331068B1 (en) 2002-12-20 2005-07-12 Benzazepine derivatives for the treatment of neurological disorders.
IS7941A IS2907B (en) 2002-12-20 2005-07-18 Benzo [d] asepin derivatives for the treatment of neurological disorders
MA28405A MA27582A1 (en) 2002-12-20 2005-07-20 BENZAZEPINE DERIVATIVES FOR THE TREATMENT OF NEUROLOGICAL DISORDERS
HK06103210.2A HK1085647A1 (en) 2002-12-20 2006-03-13 Benzo [d]azepine derivatives for the treatment of neurological disorders
US11/831,191 US7704994B2 (en) 2002-12-20 2007-07-31 Benzazepine derivatives for the treatment of neurological disorders
US12/339,145 US7799773B2 (en) 2002-12-20 2008-12-19 Benzazepine derivatives for the treatment of neurological disorders
CY20091101260T CY1109558T1 (en) 2002-12-20 2009-12-01 Benzo derivative [D] AZEPINIS FOR THE TREATMENT OF NEUROLOGICAL DISORDERS
IL202827A IL202827A (en) 2002-12-20 2009-12-17 BENZO [d]AZEPINE DERIVATIVES, THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS COMPRISING THEM
US12/707,147 US8207331B2 (en) 2002-12-20 2010-02-17 Benzazepine derivatives for the treatment of neurological disorders
JP2010157004A JP5315299B2 (en) 2002-12-20 2010-07-09 Benzodiazepine derivatives for the treatment of nervous system disorders
NO20110408A NO332218B1 (en) 2002-12-20 2011-03-17 Benzazepine derivatives, pharmaceutical compositions, methods for their preparation and their use in the treatment of neurological disorders

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0229820A GB0229820D0 (en) 2002-12-20 2002-12-20 Novel compounds

Publications (1)

Publication Number Publication Date
GB0229820D0 true GB0229820D0 (en) 2003-01-29

Family

ID=9950164

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0229820A Ceased GB0229820D0 (en) 2002-12-20 2002-12-20 Novel compounds

Country Status (3)

Country Link
CN (1) CN1326838C (en)
GB (1) GB0229820D0 (en)
ZA (1) ZA200504270B (en)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0982300A3 (en) * 1998-07-29 2000-03-08 Societe Civile Bioprojet Non-imidazole alkylamines as histamine H3 - receptor ligands and their therapeutic applications
WO2001087834A1 (en) * 2000-05-16 2001-11-22 Takeda Chemical Industries, Ltd. Melanin-concentrating hormone antagonist

Also Published As

Publication number Publication date
CN1726042A (en) 2006-01-25
CN1326838C (en) 2007-07-18
ZA200504270B (en) 2006-07-26

Similar Documents

Publication Publication Date Title
GB0202216D0 (en) Novel compounds
GB0205256D0 (en) Novel compounds
GB0202679D0 (en) Novel compounds
GB0206723D0 (en) Novel compounds
GB0211019D0 (en) Novel compounds
GB0207249D0 (en) Novel compounds
GB0207246D0 (en) Novel compounds
GB0203299D0 (en) Novel compounds
GB0200025D0 (en) Novel compounds
GB0204252D0 (en) Novel compounds
GB0206197D0 (en) Novel compounds
GB0204305D0 (en) Novel compounds
GB0201211D0 (en) Novel compounds
GB0207282D0 (en) Novel compounds
GB0207281D0 (en) Novel compounds
GB0200503D0 (en) Novel compounds
GB0207278D0 (en) Novel compounds
GB0207275D0 (en) Novel compounds
GB0206716D0 (en) Novel compounds
GB0206714D0 (en) Novel compounds
GB0206612D0 (en) Novel compounds
GB0206610D0 (en) Novel compounds
GB0206201D0 (en) Novel compounds
GB0206198D0 (en) Novel compounds
GB0200109D0 (en) Novel compounds

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)